Psoriasis Registry

CorEvitas is now part of Thermo Fisher Scientific. Read More.

STUDY VISITS

PSORIASIS PATIENTS

DERMATOLOGISTS

Participating Sites

CorEvitas has clinical sites across the U.S. and Canada and we are always interested in expanding the registry for qualified sites.

Outcome measures in the CorEvitas Psoriasis Registry.

Among the variables we collect, some of the key outcome measures to inform your psoriasis research include:

Clinician Reported Outcomes

Patient Reported Outcomes

Dermatology Life Quality Index (DLQI)
Work Productivity and Activity Impairment (WPAI)
Euro-QoL Group EQ-5D-3L
Patient Global Assessment
Psoriasis Epidemiology Screening Tool (PEST)
Pain Visual Analogue Scale
Itch Visual Analogue Scale
Fatigue Visual Analogue Scale

Registry Scientific Advisors

Bruce E. Strober, MD, PhD

Clinical Professor of Dermatology, Yale University School of Medicine | Editor in Chief, Journal of Psoriasis and Psoriatic Arthritis | Clinician, Central Connecticut Dermatology

Mark G. Lebwohl, MD

Dean for Clinical Therapeutics, Icahn School of Medicine at Mount Sinai | Professor and Chairman Emeritus, Kimberly and Eric J. Waldman Department of Dermatology | Chairman Emeritus, Medical Board, National Psoriasis Foundation | Founding Editor, Psoriasis Forum

Subscribe to our newsletter

Psoriasis Registry

Participating Sites

Outcome measures in the CorEvitas Psoriasis Registry.

Among the variables we collect, some of the key outcome measures to inform your psoriasis research include:

Clinician Reported Outcomes

Patient Reported Outcomes

Registry Scientific Advisors

Bruce E. Strober, MD, PhD

Mark G. Lebwohl, MD

Saturday September 7, 2019

Our Publications

Other Registries

Question about a registry?